Glycyrrhizinic acid is produced at PharmBioTec under GMP (§14 AMG) conditions (content 90%-102%).
The quality control of glycyrrhizic acid is carried out in the quality control department of PharmBioTec GmbH, where regular quality inspections of pharmaceutical raw materials and finished drugs are carried out at the highest level.
Each batch of glycyrrhizinic acid is produced according to established and validated manufacturing instructions, analytical methods and drug regulatory requirements and is checked for purity and content. Only the most modern, regularly maintained and qualified, state-of-the-art equipment is used for the production and testing of the products to ensure the reliability of the data collected. The highly qualified employees are continuously trained by internal and external courses and further education. Regular GMP inspections certify that PharmBioTec GmbH complies with the GMP guidelines.
Regular quality control ensures that only glycyrrhizinic acid that meets the highest quality standards is released. Glycyrrhizinic acid is therefore suitable as an active ingredient for all conceivable application sites; from topical, oral to parenteral - glycyrrhizinic acid is available for a wide range of therapeutic options.